Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adaptive Biotechnologies Corp shares valued at $17,149 were sold by PISKEL KYLE on May 16 ’25. At $8.89 per share, PISKEL KYLE sold 1,929 shares. The insider’s holdings dropped to 277,396 shares worth approximately $4.31 million following the completion of this transaction.
Also, ROBINS HARLAN S sold 68,412 shares, netting a total of over 502,828 in proceeds. Following the sale of shares at $7.35 each, the insider now holds 1,279,524 shares.
Before that, Harlan Robins had added 68,412 shares to its account. In a trade valued at $503,512, the Officer bought Adaptive Biotechnologies Corp shares for $7.36 each.
As published in their initiating research note from Guggenheim on September 30, 2025, Adaptive Biotechnologies Corp [ADPT] has been a Buy and the price target has been revised to $20. Analysts at Craig Hallum started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of March 21, 2025, Goldman has increased its “Neutral” rating to a “Buy” for ADPT.
Analyzing ADPT Stock Performance
On last trading session, Adaptive Biotechnologies Corp [NASDAQ: ADPT] rose 8.36% to $15.55. The stock’s lowest price that day was $14.3876, but it reached a high of $15.575 in the same session. During the last five days, there has been a surge of approximately 6.80%. Over the course of the year, Adaptive Biotechnologies Corp shares have jumped approximately 181.70%. Shares of the company reached a 52-week high of $15.57 on 10/08/25 and a 52-week low of $5.96 on 01/02/25.
Support And Resistance Levels for Adaptive Biotechnologies Corp (ADPT)
According to the 24-hour chart, there is a support level at 14.77, which, if violated, would cause prices to drop to 13.98. In the upper region, resistance lies at 15.95. The next price resistance is at 16.36. RSI (Relative Strength Index) is 66.90 on the 14-day chart, showing neutral technical sentiment.
Is Adaptive Biotechnologies Corp subject to short interest?
Stocks of Adaptive Biotechnologies Corp saw a sharp rise in short interest on 2025-09-15 jumping by 0.4 million shares to 9.34 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 8.95 million shares. A jump of 4.28% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.09 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.09.
Which companies own the most shares of Adaptive Biotechnologies Corp (ADPT)?
In terms of Adaptive Biotechnologies Corp share price expectations, FactSet research, analysts set an average price target of 20 in the next 12 months, up nearly 39.37% from the previous closing price of $14.35. Analysts anticipate Adaptive Biotechnologies Corp stock to reach 20 by 2025, with the lowest price target being 20. In spite of this, 11 analysts ranked Adaptive Biotechnologies Corp stock as Hold at the end of 2025. On January 05, 2023, Scotiabank assigned a price target of “a Sector outperform” to the stock and initiated coverage with a $15.
